Evidence map›Paper›PMID 36228251›Full record

ArticleRevista da Associacao Medica Brasileira (1992)2022

Adjunctive corticosteroid therapy in patients with pulmonary tuberculosis.

Carolina Xavier Lemos, Camila Anton, Felipe Dominguez Machado, Rafaela Manzoni Bernardi, Alana Ambos Freitas, Denise Rossato Silva

Open access · diamondAbstract read
In one paragraph

Article in Revista da Associacao Medica Brasileira (1992), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Carolina Xavier LemosUniversidade Federal do Rio Grande do Sul, Graduate Program in Pulmonology Sciences - Porto Alegre (RS), Brazil.ORCID http://orcid.org/0000-0003-4511-4848
Camila AntonUniversidade Federal do Rio Grande do Sul, Graduate Program in Pulmonology Sciences - Porto Alegre (RS), Brazil.ORCID http://orcid.org/0000-0003-2288-6351
Felipe Dominguez MachadoUniversidade Federal do Rio Grande do Sul, Graduate Program in Pulmonology Sciences - Porto Alegre (RS), Brazil.ORCID http://orcid.org/0000-0001-5868-7974
Rafaela Manzoni BernardiUniversidade Federal do Rio Grande do Sul, Graduate Program in Pulmonology Sciences - Porto Alegre (RS), Brazil.ORCID http://orcid.org/0000-0003-4424-0113
Alana Ambos FreitasUniversidade Federal do Rio Grande do Sul, School of Medicine - Porto Alegre (RS), Brazil.ORCID http://orcid.org/0000-0003-3673-7357
Denise Rossato SilvaUniversidade Federal do Rio Grande do Sul, Graduate Program in Pulmonology Sciences - Porto Alegre (RS), Brazil.ORCID http://orcid.org/0000-0003-0230-2734
Universidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIn tuberculosis treatment, corticosteroids are used as adjuvants, especially in meningeal/pericardial tuberculosis. In other forms of the disease, especially in severe tuberculosis requiring mechanical ventilation, its use is controversial. The aim of the present study is to assess whether the use of corticosteroids in the treatment of pulmonary tuberculosis patients in mechanical ventilation is associated with in-hospital mortality.

methodsThis is a retrospective cohort study. Tuberculosis patients >18 years requiring mechanical ventilation, admitted to the emergency department or intensive care unit, were included. Data on corticosteroid use and mortality were collected.

resultsIn total, 467 patients were included in the analysis; 399 used corticosteroids and 68 were noncorticosteroid users. The mortality rate was higher among corticosteroid users (59.9%) than in noncorticosteroid users (41.2%) (p=0.010). The total dose of corticosteroid in prednisone equivalents was not different between survivors and nonsurvivors (median [interquartile range]: 80 mg [5-56.6 mg] vs. 80 mg [50-135 mg]; p=0.881).

conclusionsTuberculosis patients in mechanical ventilation who used corticosteroids had a higher mortality rate than those who did not use corticosteroids. The role of corticosteroids in pulmonary tuberculosis, especially in critically ill patients, remains unclear and needs further evaluation in prospective studies.

Indexed as

TuberculosisTuberculosis, PulmonaryAdrenal Cortex HormonesCritical IllnessHumansIntensive Care UnitsPrednisoneProspective StudiesRespiration, ArtificialRetrospective StudiesAdrenal Cortex HormonesPrednisone

Identifiers

PMID36228251
PMCPMC9575022
OpenAlexW4303438213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.